Literature DB >> 9817562

Cisapride-induced torsades de pointes.

J Vitola1, J Vukanovic, D M Roden.   

Abstract

Two cases of torsades de pointes associated with cisapride are presented, both in association with concomitant drug therapy that inhibits cisapride biotransformation. In one case, plasma cisapride was elevated days after the event, strongly supporting a role for accumulation of the drug in causing the arrhythmia. It is emphasized that these adverse drug reactions are not idiosyncratic, but rather are predictable based on an understanding of the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817562     DOI: 10.1111/j.1540-8167.1998.tb00888.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  13 in total

Review 1.  Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.

Authors:  Deborah L Wolbrette
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 2.  Prolonged QTc interval in cancer therapeutic drug development: defining arrhythmic risk in malignancy.

Authors:  Joanna M Brell
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

3.  Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.

Authors:  Michael Perrio; Simon Voss; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 4.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 5.  Risk factors for drug-induced long-QT syndrome.

Authors:  A D C Paulussen; J Aerssens
Journal:  Neth Heart J       Date:  2005-02       Impact factor: 2.380

6.  Evidence of impaired cisapride metabolism in neonates.

Authors:  J M Tréluyer; E Rey; M Sonnier; G Pons; T Cresteil
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

7.  Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG.

Authors:  Weiwei Wang; Roderick MacKinnon
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 8.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Prokinetics in the Management of Functional Gastrointestinal Disorders.

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2017-09-08

10.  Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials.

Authors:  Matías E Manzotti; Hugo N Catalano; Fernando A Serrano; Gisela Di Stilio; María F Koch; Gordon Guyatt
Journal:  Open Med       Date:  2007-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.